We collectively studied the targeting property of CD90@17-AAG/TMs in HCC-bearing mice and explored the antitumor effect and mechanism of CD90@17-AAG/TMs against CD90+ LCSCs under hyperthermic conditions in vivo. Here, THY1 is linked to hepatocellular carcinoma.